Back to Group One Trading LLC Group One Trading LLC

QNCX

17 quarters

Position history for Group One Trading LLCGroup One Trading LLC's holdings in QUINCE THERAPEUTICS INC

No. Group One Trading exited its QNCX (Quince Therapeutics) position in Q1 2026. Its Q4 2025 13F listed 140,477 shares worth $470,598. Group One Trading first reported QNCX in Q3 2020 and held it in 12 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$1,000

Total Shares Change

-12

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Exited
0
-100.0%
$00.0%$20.20
0
2025-Q4
Increased
140,477
+355.6%
$470,5980.0%$670.00
39
2025-Q3
New
30,830
-
$50,2530.0%$326.00
28
2025-Q2
Exited
0
-100.0%
$00.0%$330.00
0
2025-Q1
New
246
-
$3270.0%$266.00
17
2024-Q3
Exited
0
-100.0%
$00.0%$155.20
0
2024-Q2
Decreased
1,600
-0.5%
$1,2000.0%$150.00
0
2024-Q1
New
1,608
-
$1,7040.0%$212.00
17
2023-Q1
Exited
0
-100.0%
$00.0%$312.00
0
2022-Q4
Decreased
40,745
-70.3%
$25,9710.0%$127.40
0
2022-Q3
Decreased
137,058
-2.1%
$182,0000.0%$266.00
0
2022-Q2
Increased
140,032
+34.1%
$311,0000.0%$444.00
30
2022-Q1
New
104,456
-
$647,0000.0%$1,238.00
34
2021-Q2
Exited
0
-100.0%
$00.0%$10,600.00
0
2021-Q1
Increased
3,596
+595.5%
$130,0000.0%$7,206.00
36
2020-Q4
Increased
517
+4208.3%
$14,0000.0%$5,556.00
20
2020-Q3
New
12
-
$1,0000.0%$10,000.00
17

Other major holders of QNCX: Capital World Investors, Capital International Investors, Capital Research Global Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used